{"id":4740,"date":"2014-10-31T12:18:27","date_gmt":"2014-10-31T11:18:27","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=4740"},"modified":"2014-10-31T12:18:27","modified_gmt":"2014-10-31T11:18:27","slug":"chiesi-causa-in-usa-4-brevetti-farmaci-per-pressione","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/chiesi-causa-in-usa-4-brevetti-farmaci-per-pressione\/","title":{"rendered":"I asked. US lawsuit over 4 blood pressure drug patents"},"content":{"rendered":"

Chiesi has not used original active ingredients, but has patented their method of administration<\/em><\/p>\n

Posted by\u00a0Editorial board<\/a>\u00a0on 30\/10\/2014 in\u00a0Economy<\/a>,\u00a0Newsletters<\/a> \u2013 ParmaQuotidiano.net<\/a><\/p>\n

\"\"A US distributor of generic drugs has sued Chiesi, a well-known pharmaceutical multinational based in Parma, contesting four patents relating to drugs for high blood pressure. Chiesi has not used original active ingredients, but has patented their method of administration, in an easily usable single-dose form.<\/p>\n

The lawsuit was filed in New Jersey federal court by Sandoz Inc., which claims that Chiesi's patented dosage of four different drugs distributed through the former Cornerstone Therapeutics - recently absorbed by Chiesi - were actually already in use.<\/p>\n

 <\/p>","protected":false},"excerpt":{"rendered":"

Chiesi non ha utilizzato principi attivi originali, ma ha brevettato la loro modalit\u00e0 di somministrazione Posted by\u00a0Redazione\u00a0on 30\/10\/2014 in\u00a0Economia,\u00a0Newsletter \u2013 ParmaQuotidiano.net Un distributore di farmaci generici statunitense ha fatto causa alla Chiesi, nota multinazionale farmaceutica con sede a Parma, contestando quattro brevetti relativi a farmaci contro l\u2019alta pressione. Chiesi non ha utilizzato principi attivi originali, …<\/p>","protected":false},"author":4,"featured_media":4742,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[31,22],"class_list":["post-4740","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-generici","tag-truffa-farmaci"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/4740","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=4740"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/4740\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/4742"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=4740"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=4740"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=4740"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}